STM publisher Elsevier has announced that it is now offering its Gold Standard Drug Database (GSDD) Application Program Interface (API) in the Elsevier cloud powered by Amazon Web Services. This new optional delivery method will make it easier for clients to receive and integrate data feeds, thereby saving time and resources, people and hardware.
Benefits of the web-accessible, cloud-hosted GSDD solution suite include: easy integration with existing technology without significant cost; faster updates; elimination of hardware storage and physical maintenance costs; improved data safety; and robust disaster recovery capabilities.
Karthik Krishnan, Senior Vice President, Clinical Reference & Workflow, Elsevier Clinical Solutions, said that offering the GSDD database in the Elsevier cloud provides significant benefits to the client, including the flexibility to connect (API) with existing business systems.
The new cloud-hosted web API joins Elsevier's existing GSDD delivery options in technological superiority among drug databases. Features unique to GSDD include: TRUE Daily Updates™; patient safeguards; superior technology; and adaptation for industry needs.
Elsevier's GSDD is the next-generation drug database and drug decision support engine, fulfilling complex and evolving drug information needs throughout the healthcare system. GSDD enables healthcare professionals to quickly make fully informed decisions on drug prescribing, dispensing, adjudication and analysis. GSDD delivers the most current, accurate and relevant drug data with TRUE Daily Updates™, eliminating alert fatigue and delivering appropriate answers according to the healthcare setting.
Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
